- Home
- GNFT vs NRO Comparison
GNFT vs NRO Comparison
Compare GNFT & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- NRO
- Stock Information
- Founded
- GNFT 1999
- NRO 2003
- Country
- GNFT France
- NRO United States
- Employees
- GNFT N/A
- NRO N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- NRO Finance/Investors Services
- Sector
- GNFT Health Care
- NRO Finance
- Exchange
- GNFT Nasdaq
- NRO Nasdaq
- Market Cap
- GNFT 179.7M
- NRO 170.5M
- IPO Year
- GNFT 2019
- NRO N/A
- Fundamental
- Price
- GNFT $3.91
- NRO $3.35
- Analyst Decision
- GNFT Strong Buy
- NRO
- Analyst Count
- GNFT 1
- NRO 0
- Target Price
- GNFT $13.00
- NRO N/A
- AVG Volume (30 Days)
- GNFT 9.9K
- NRO 239.4K
- Earning Date
- GNFT 09-19-2024
- NRO 01-01-0001
- Dividend Yield
- GNFT N/A
- NRO 11.41%
- EPS Growth
- GNFT N/A
- NRO N/A
- EPS
- GNFT 0.47
- NRO N/A
- Revenue
- GNFT $86,225,222.00
- NRO N/A
- Revenue This Year
- GNFT $145.20
- NRO N/A
- Revenue Next Year
- GNFT N/A
- NRO N/A
- P/E Ratio
- GNFT $7.89
- NRO N/A
- Revenue Growth
- GNFT 175.45
- NRO N/A
- 52 Week Low
- GNFT $3.35
- NRO $2.51
- 52 Week High
- GNFT $6.42
- NRO $3.45
- Technical
- Relative Strength Index (RSI)
- GNFT 54.95
- NRO 38.13
- Support Level
- GNFT $3.68
- NRO $3.33
- Resistance Level
- GNFT $3.96
- NRO $3.45
- Average True Range (ATR)
- GNFT 0.13
- NRO 0.07
- MACD
- GNFT 0.05
- NRO -0.01
- Stochastic Oscillator
- GNFT 79.49
- NRO 5.56
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").